# Vistel

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vistel

- Industry: Healthcare IT
- Headquarters: Beijing, China
- Website: www.vistel.cn
- Total disclosed funding: $18M
- Latest round: Series B (Aug 23, 2021)
- Investors on record: 2

## About

Based in Beijing, China and established in 2016, Vistel is a medical technology company which optical diagnose system for hospitals based on artificial intelligent (AI), data and image analysis, and cloud technology. The company was jointly founded by Yuhui Sun, he was the Intel executive, and the researcher Dayong Ding. At present, the laboratory has more than 20 doctors and masters who focus on the research in the field of medical imaging. The technical team has experience in the fields of computer vision processing, artificial intelligence, image annotation and big data computing. In August 2021, the company raised series B funding led by Qiming Venture Partners, and followed by Redhill Capital.

The company provides visual health products, including AI screening and evaluation of blinding eye diseases, intelligent image management, telemedicine system and myopia prevention.

The latest financing funds will be used for team expansion, product research and development, clinical project registration and market development.

## Funding rounds

- Series B, Aug 23, 2021, $15M — Qiming Venture Partners, Redhill Capital
- Series A, Mar 27, 2019, $0.1M — Redhill Capital
- Series A, Aug 1, 2018, $2.9M — Redhill Capital

## Investors

- Redhill Capital (https://capitalatlas.ai/funds/redhill-capital) — Series A, Series B
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B